TrialJournal for immunotherapy of cancer2025

Nemvaleukin alfa monotherapy in patients with advanced melanoma and renal cell carcinoma: results from the phase 1/2 non-randomized ARTISTRY-1 trial.

Emiliano Calvo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.